As a Cardiovascular Epidemiologist at Imperial College London, I specialize in the Familial Hypercholesterolaemia Studies Collaboration (FHSC) Registry. My work with the FHSC focuses on identifying modifiable risk factors for cardiovascular events in FH patients and mapping the genetic mutation spectrum worldwide. My background includes a PhD and postdoc at the University of Oxford, where I combined medical knowledge with epidemiological analysis to reveal the role of amino acids in regulating fat mass in humans and their potential as an anti-obesity drug target.